gastrointestin
viral
pathogen
great
social
econom
impact
develop
develop
nation
gastrointestin
virus
shed
human
fecal
wast
transmit
orofec
rout
direct
contact
infect
person
consumpt
contact
contamin
water
food
buesa
knipe
howley
intestin
viral
infect
usual
result
diarrhea
vari
degre
oral
parenter
rehydr
therapi
common
treatment
howev
grow
interest
use
probiot
antivir
therapi
due
posit
influenc
human
health
probiot
defin
live
microorgan
upon
ingest
certain
quantiti
exert
benefici
effect
host
common
probiot
member
lactic
acid
bacteria
lactobacillu
streptococcu
enterococcu
etc
bifidobacteria
yeast
strain
microorgan
gener
recogn
safe
long
histori
use
food
product
normal
inhabit
gastrointestin
tract
ecosystem
colon
divers
microbiota
locat
reach
microorgan
per
gram
content
constitut
approxim
differ
speci
make
one
dens
complex
microbi
ecosystem
intestin
microbiota
play
import
role
organ
physiolog
help
maintain
host
health
collado
et
al
thu
imbal
composit
dysbiosi
underli
patholog
eg
inflammatori
bowel
diseas
gutassoci
immun
system
display
hyporespons
resid
microbiota
sensit
product
deriv
socal
microbialassoci
molecular
pattern
dna
compon
cell
wall
protein
etc
sens
complex
famili
receptor
present
epitheli
immunocompet
cell
eg
tolllik
receptor
tlr
crosstalk
establish
microbiota
epithelialimmun
cell
influenc
cell
prolifer
matur
help
maintain
immun
homeostasi
gut
barrier
function
gill
prasad
epithelium
intestin
microbiota
constitut
synerg
physic
chemic
defens
line
pathogen
defens
function
suscept
modul
use
probiot
mani
health
benefit
attribut
probiot
prevent
treatment
intestin
infect
prevent
manag
allerg
diseas
enhanc
immun
function
anticanc
effect
cholesterol
lower
etc
accumul
clinic
data
point
treatment
prevent
infecti
diarrhea
one
health
effect
support
sound
scientif
evid
besid
antibacteri
activ
mani
studi
demonstr
specif
probiot
reduc
risk
shorten
durat
diarrhea
associ
viral
infect
especi
infant
children
sever
type
virus
abl
replic
intestin
epithelium
caus
gastroenter
buesa
knipe
howley
follow
section
import
viral
group
respons
gastrointestin
infect
worldwid
describ
norovirus
nv
member
calicivirida
famili
infect
small
intestin
caus
major
foodborn
waterborn
outbreak
acut
gastroenter
worldwid
nv
contain
linear
positivesens
singlestrand
rna
genom
high
genet
variabl
classifi
five
genogroup
gigv
subdivid
genotyp
major
nv
infect
human
belong
gi
gii
genogroup
genotyp
emerg
main
genotyp
caus
gastroenter
outbreak
worldwid
incub
time
rang
h
lead
gastroenter
h
begin
symptom
nv
infect
usual
cours
selflimit
diarrhea
character
vomit
special
case
lead
sever
dehydr
death
rotavirus
rv
main
etiolog
caus
sever
gastroenter
infantil
morbid
worldwid
children
year
age
popul
seroconvert
thu
less
suscept
rv
infect
rv
also
lead
high
childhood
mortal
develop
countri
caus
death
per
year
result
dehydr
defici
medic
care
develop
countri
rv
diarrhea
respons
larg
number
hospit
although
rv
vaccin
develop
last
year
econom
altern
would
desir
especi
develop
countri
rv
icosahedr
virus
belong
famili
reovirida
infect
matur
enterocyt
seven
rv
serogroup
ag
describ
base
antigen
capsid
protein
human
pathogen
belong
group
b
c
rv
group
import
public
health
standpoint
viru
compos
three
protein
shell
outer
capsid
inner
capsid
intern
core
surround
segment
doublestrand
rna
three
major
structur
nonstructur
protein
interest
epidemiolog
studi
vaccin
develop
group
rv
genotyp
af
g
genotyp
p
genotyp
special
interest
abl
elicit
neutral
antibodi
astrovirus
av
nonenvelop
virus
positivesens
singlestrand
rna
genom
av
infect
occur
worldwid
incid
rang
develop
develop
countri
outbreak
av
associ
consumpt
sewagepollut
shellfish
ingest
water
contamin
sourc
enter
adenovirus
adv
nonenvelop
doublestrand
dna
icosahedr
virus
measur
nm
diamet
adv
divid
two
genera
mastadenoviru
includ
virus
infect
mammal
aviadenoviru
contain
virus
infect
bird
countri
enter
adv
subtyp
place
second
etiolog
agent
infantil
gastroenter
enterovirus
ev
name
site
replic
rare
caus
gastroenter
result
infect
frequent
asymptomat
target
organ
ev
belong
famili
picornavirida
possess
positivesens
rna
genom
two
main
repres
ev
poliovirus
caus
poliomyel
kubovirus
aichi
viru
member
genu
kuboviru
respons
gastroenter
outbreak
usual
caus
consumpt
contamin
oyster
mechan
antagonist
capac
probiot
microbi
pathogen
exhaust
investig
microorgan
import
gastrointestin
infect
clostridium
difficil
helicobact
pylori
salmonella
pathogen
escherichia
coli
numer
vitro
clinic
studi
exist
posit
effect
attribut
multipl
mechan
servin
also
extend
virus
summar
figur
probiot
abl
induc
host
cellular
defens
pathogen
bacteria
bdefensin
synthes
paneth
cell
also
produc
wellcharacter
antibacteri
molecul
organ
acid
h
antimicrobi
peptid
bacteriocin
author
postul
certain
probiot
produc
antivir
substanc
seo
et
al
although
natur
unknown
vitro
viral
inhibit
bacteri
supernat
might
simpli
explain
presenc
organ
acid
one
first
viral
infect
mechan
target
probiot
viral
bind
host
cell
exclus
pathogen
direct
bind
attach
inhibit
displac
thoroughli
studi
bacteri
pathogen
vitro
vivo
studi
use
probiot
data
exclus
virus
scarc
virus
use
oligosaccharid
present
glycoconjug
cellular
surfac
receptor
attach
entri
rv
recogn
sialic
acid
nacetylneuramin
acid
residu
first
step
cellular
entri
wherea
nv
display
bind
specif
toward
carbohydr
carbohydr
form
part
histoblood
group
antigen
express
mucos
surfac
mani
lactobacillu
bifidobacterium
strain
display
lectinlik
activ
surfac
surfac
compon
bacteria
character
bind
highli
glycosyl
intestin
mucu
extracellular
matrix
protein
respons
attach
cultur
enterocyt
line
eg
cell
line
lebeer
et
al
surfac
layer
protein
slpa
lactobacillu
implic
attach
cellular
surfac
pathogen
displac
surfac
protein
evid
secret
signal
eg
chaperon
glycolyt
enzym
decor
surfac
lactobacillu
plantarum
lactobacillu
casei
lactobacillu
reuteri
lactobacillu
johnsonii
strain
behav
sticki
factor
play
role
adhes
lactobacillu
speci
adapt
gastrointestin
nich
l
plantarum
lactobacillu
acidophilu
lactobacillu
gasseri
l
johnsonii
l
reuteri
possess
surfacespeci
protein
involv
mucin
bind
mannosesensit
manner
lectinlik
specif
mucinbind
pili
case
lactobacillu
rhamnosu
gg
molecul
nonprotein
natur
present
bacteri
surfac
report
involv
bind
lipoteicho
acid
exopolysaccharid
type
molecul
allow
probiot
attach
intestin
mucos
surfac
might
respons
persist
nich
addit
particip
viral
exclus
displac
surfac
target
cell
besid
probiot
strain
abl
directli
bind
virus
would
promot
elimin
fece
impli
surfac
molecul
glycosyl
protein
compon
cell
wall
probiot
could
mimick
viral
receptor
interestingli
two
strain
l
rhamnosu
gg
bifidobacterium
lacti
betterdocu
efficaci
infecti
diarrhea
exhibit
best
bind
abil
rv
particl
salminen
et
al
probiot
modul
specif
host
pathway
induc
synthesi
molecul
interfer
step
viral
cycl
increas
mucos
barrier
function
act
immunomodul
enhanc
innat
adapt
immun
respons
studi
address
synthesi
reactiv
oxygen
speci
ro
cultur
epitheli
cell
presenc
probiot
ro
play
defens
role
organ
correl
ro
releas
induct
viral
protect
specif
pair
cultur
cell
linesprobiot
strain
describ
maragkoudaki
et
al
l
rhamnosu
gg
l
plantarum
stimul
mucin
secret
upregul
gene
cell
respect
increas
mucin
secret
form
part
epitheli
mucu
protect
layer
may
particip
viral
exclus
bind
entrap
virus
specif
mucinvir
interact
promot
shed
intestin
act
physic
barrier
limit
access
epithelium
viral
diarrhea
involv
vari
mechan
result
defici
nutrient
absorpt
increas
secret
water
electrolyt
infect
paracellular
epitheli
permeabl
increas
epitheli
damag
apoptosi
occur
l
rhamnosu
gg
member
l
caseirhamnosu
group
secret
cultur
mediumspecif
protein
enhanc
barrier
function
mechan
involv
akt
kinas
protect
intestin
epithelium
injuri
apoptosi
caus
inflammatori
cytokin
tumor
necrosi
factor
tnfa
interferon
gamma
ifng
oxid
damag
maintain
structur
tight
junction
increas
express
specif
protein
eg
zonula
claudin
occludin
lowmolecularweight
peptid
produc
l
rhamnosu
gg
activ
mitogenactiv
protein
kinas
induc
cytoprotect
heatshock
protein
intestin
cell
gener
probiot
strain
maintain
epitheli
integr
reduc
decreas
transepitheli
resist
cultur
follow
pathogen
infect
thu
may
help
keep
intestin
barrier
integr
compromis
viral
infect
vitro
vivo
experi
establish
probiot
modul
synthesi
array
cytokin
exampl
interleukin
il
ifng
tnfa
lead
rang
modulatori
effect
immun
cell
increas
cytotox
phagocyt
capac
nk
cell
macrophag
immun
cell
b
lymphocyt
prolifer
differenti
result
increas
antibodi
respons
gill
prasad
consumpt
ferment
milk
contain
certain
probiot
increas
specif
igg
iga
titer
individu
vaccin
salmonella
hepat
b
influenza
polioviru
sens
l
rhamnosu
gg
effect
promot
specif
igasecret
cell
higher
plasma
iga
titer
rv
infect
kaila
et
al
show
adjuv
effect
rv
vaccin
data
effect
probiot
viral
gastrointestin
infect
use
vitro
vivo
model
obtain
rv
deriv
fact
util
anim
model
shed
light
mechan
implic
benefici
effect
probiot
counteract
gastrointestin
viral
infect
addit
provid
tool
screen
viral
protect
confer
differ
probiot
strain
first
relev
data
posit
effect
probiot
bacteria
use
anim
model
obtain
model
suckl
rat
group
b
rv
strain
idir
isolauri
et
al
work
show
diet
supplement
l
rhamnosu
gg
decreas
jejun
permeabl
macromolecul
produc
rv
infect
thu
provid
first
evid
protect
mechan
probiot
rv
milk
ferment
bifidobacterium
bifidum
l
casei
assay
effect
mice
germfre
suckl
rat
respect
demonstr
surviv
colon
digest
tract
probiot
link
reduc
diarrhea
viral
shed
infect
group
rv
duffi
et
al
guerindanan
et
al
murin
model
also
util
assess
effect
l
rhamnosu
gg
combin
iga
antibodi
rv
combin
result
effect
prophylaxi
rv
diarrhea
reduc
viru
load
intestin
prevent
histopatholog
chang
significantli
reduc
diarrhea
outcom
measur
pant
et
al
piglet
model
also
employ
studi
efficaci
probiot
treatment
well
investig
mechan
confer
protect
b
lacti
reduc
diarrhea
associ
rv
piglet
model
show
potenti
use
probiot
farm
reduc
sever
weanl
diarrhea
improv
feed
convers
effici
associ
reduct
rv
fece
increas
intestin
pathogenspecif
antibodi
titer
work
postul
enhanc
immunemedi
respons
possibl
mechan
benefici
effect
probiot
shu
et
al
follow
postul
studi
virusspecif
b
cell
respons
induc
attenu
virul
wa
human
rv
strain
gnotobiot
piglet
without
l
acidophilu
l
reuteri
colon
demonstr
enhanc
immun
rv
confer
probiot
zhang
et
al
studi
complet
use
l
acidophilu
l
reuteri
virul
human
wa
rv
strain
assay
distribut
matur
antigenpres
cell
author
show
differenti
distribut
frequenc
monocytesmacrophag
dendrit
cell
furthermor
differ
matur
marker
differenti
activ
tlr
innat
immun
cytokin
ifng
observ
identifi
enhanc
immun
respons
possibl
mechan
viral
protect
wen
et
al
zhang
et
al
cell
cultur
system
report
provid
evid
viral
protect
confer
probiot
strain
use
nontumorigen
porcin
intestin
epitheli
cell
alveolar
macrophag
studi
aim
elucid
protect
abil
seek
mechanist
explan
effect
sever
probiot
model
viru
vesicular
stomat
viru
vsv
seven
differ
probiot
strain
bifidobacterium
breve
dsm
bifidobacterium
longum
lactobacillu
paracasei
l
paracasei
l
paracaseirhamnosu
l
plantarum
l
reuteri
dsm
analyz
protect
confer
strain
prevent
vsv
cellular
bind
cell
monolay
preincub
strain
h
prior
viral
challeng
furthermor
previou
adsorpt
vsv
directli
probiot
effect
give
mechanist
explan
observ
protect
cultur
supernat
probiot
assay
elucid
abl
produc
antivir
metabolit
three
strain
b
longum
l
plantarum
l
reuteri
dsm
produc
metabolit
abl
reduc
viral
infect
similar
result
obtain
cultur
supernat
l
reuteri
strain
isol
pig
fece
block
viral
infect
group
porcin
rv
african
green
monkey
epitheli
cell
line
seo
et
al
ivec
collabor
show
four
strain
previous
assay
botic
studi
l
paracaseirhamnosu
l
paracasei
l
paracasei
b
longum
abl
reduc
viral
infect
macrophag
increas
antivir
respons
vsv
measur
ifng
nitric
oxid
product
thu
confirm
crosstalk
probiot
macrophag
ivec
et
al
cell
model
use
studi
influenc
probiot
innat
immun
respons
rv
two
probiot
strain
known
antirotavir
effect
util
l
acidophilu
ncfm
l
rhamnosu
gg
none
abl
protect
cell
cultur
porcin
rv
osu
strain
infect
l
acidophilu
abl
increas
respons
consist
adjuv
effect
l
acidophilu
contrari
l
rhamnosu
gg
abl
increas
express
decreas
level
confirm
antiinflammatori
effect
liu
et
al
line
experi
prime
bovin
intestin
epitheli
cell
l
plantarum
prior
rv
infect
result
upregul
gene
involv
innat
immun
ifna
ifnb
decreas
viru
infect
thompson
et
al
gener
attempt
use
cell
cultur
model
find
common
mechan
confer
viral
resist
fail
provid
evid
protect
confer
multifactori
mechan
depend
viral
agent
cell
line
util
probiot
strain
maragkoudaki
et
al
due
worldwid
preval
alreadi
mention
laboratori
evid
clinic
studi
effect
probiot
gastrointestin
virus
focus
incid
rv
acut
diarrhea
children
howev
note
divers
etiolog
make
difficult
assign
episod
infecti
diarrhea
particular
pathogen
without
proper
serolog
microbiolog
molecular
studi
number
random
placebocontrol
trial
demonstr
oral
intak
certain
strain
particularli
l
rhamnosu
gg
b
lacti
promot
faster
recoveri
acut
rv
diarrhea
shorten
diarrhea
day
reduc
symptom
sever
tabl
moreov
probiot
well
toler
advers
effect
gener
report
posit
result
also
document
probiot
infecti
diarrhea
nonrv
origin
antibioticassoci
diarrhea
support
use
probiot
adjuv
therapi
combin
classic
rehydr
howev
studi
prophylact
use
probiot
reduc
risk
diarrhea
children
day
care
center
nosocomi
diarrhea
origin
rv
produc
modest
evid
conflict
result
exampl
studi
conduct
hospit
children
oral
given
two
daili
dose
l
rhamnosu
gg
bacteri
cell
result
reduct
incid
rv
diarrhea
szajewska
et
al
contrari
daili
intak
bacteria
strain
children
show
effect
risk
rv
diarrhea
compar
placebo
mastretta
et
al
unfortun
clinic
data
mere
descript
provid
mechanist
explan
confer
benefit
clear
confirm
diarrhea
etiolog
exampl
reduc
viral
shed
fece
fang
et
al
mao
et
al
rosenfeldt
et
al
increas
immun
respons
iga
level
shown
kaila
et
al
fact
probiot
gener
colon
gastrointestin
tract
persist
transient
suggest
benefit
evidenc
probiot
supplement
phase
sustain
protect
therefor
daili
intak
high
amount
cell
viabl
cell
case
need
reach
requir
minim
effect
dose
vitro
vivo
clinic
trial
provid
conclus
result
efficaci
probiot
intestin
virus
treatment
acut
diarrhea
children
seem
justifi
area
applic
although
efficaci
probiot
gastrointestin
viral
infect
adult
still
question
research
field
probiot
applic
need
howev
address
sever
key
issu
heterogen
experiment
design
number
patient
analys
diarrhea
outcom
measur
make
evalu
differ
clinic
trial
difficult
warrant
design
standard
trial
higher
number
subject
order
obtain
bettersupport
conclus
help
defin
better
treatment
protocol
establish
dose
frequenc
specif
strain
ii
research
extend
virus
differ
rv
import
agent
caus
gastroenter
nv
new
infect
model
need
adequ
identif
infecti
agent
viral
bacteri
natur
clinic
trial
requir
iii
report
effect
strain
specif
proven
probiot
l
rhamnosu
gg
strain
higher
number
clinic
trial
conduct
shown
effect
rv
effect
enteropathogen
bacteria
contrari
strain
shown
effect
diarrhea
viral
nonvir
origin
collect
probiot
need
screen
antivir
effect
specif
strain
abl
inhibit
differ
virus
identifi
avail
sever
vitro
cell
line
anim
model
infect
help
screen
detail
investig
molecular
mechan
probioticderiv
compound
mediat
effect
although
immunomodul
emerg
main
plausibl
explan
antivir
effect
underli
mechan
far
understood
constitut
interest
research
field
futur
